All Vaccinology articles
-
NewsMeasles cases surge worldwide, infecting 10.3 million people in 2023
Worldwide, there were an estimated 10.3 million cases of measles in 2023, a 20% increase from 2022, inadequate immunization coverage globally is driving the surge in cases.
-
NewsPotential single-dose smallpox and mpox vaccine moves forward
Scientists report on studies suggesting that the horsepox virus in the experimental vaccine is substantially more attenuated—and less likely to trigger a systemic infection—than the vaccinia virus used in the single-dose vaccine already approved by the FDA.
-
NewsStudy reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Researchers found that getting vaccinated on the early side of the recommended window was best for transferring maternal antibodies to the fetus.
-
NewsAcquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
A new study presents two cases of immune thrombotic thrombocytopenic purpura occurring after the administration of the inactivated vaccine CoronaVac from Sinovac Biotech, highlighting the potential association between this type of vaccine and TTP.
-
NewsSecond round of polio campaign in Gaza completed amid ongoing conflict and attacks
The second round of the polio vaccination campaign in the Gaza Strip was completed yesterday, with an overall 556 774 children under the age of 10 being vaccinated with a second dose of polio vaccine.
-
NewsMen who have sex with men in Europe still vulnerable to hepatitis A and B
Research analysing European survey data from 113,884 men who have sex with men (MSM) indicates that while most MSM have a basic understanding of viral hepatitis, only 44% report having been vaccinated against both hepatitis A and B.
-
NewsStudy reveals vaccination patterns among LGBTQ+ adults in New Jersey and New York
A new study led by Rutgers Health researchers has uncovered important insights into vaccination patterns among LGBTQ+ adults in New Jersey and New York. The findings shed light on disparities in vaccine uptake within this diverse population.
-
NewsStudy reveals stubborn mistrust in COVID-19 vaccine science
A new study sheds light on public trust in COVID-19 vaccine science and its impact on vaccine acceptance in the United States from 2021 to 2023, finding that around one-third of respondents expressed mistrust in the science behind COVID-19 vaccines.
-
NewsRSV vaccines effective, but more people need to get them
Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines.
-
NewsVaccinating children for mpox would significantly reduce deaths in the DRC
Vaccinating children under five-years-old in endemic mpox regions in the Democratic Republic of the Congo (DRC) would significantly reduce the number of deaths in the country, according to a new analysis.
-
NewsRepeated COVID vaccines enhance mucosal immunity against the virus
New work has found that repeated Covid-19 vaccinations lead to the presence of mucosal antibodies, for example, inside the nose.
-
NewsMERS coronavirus vaccine tested as safe and effective in phase Ib clinical trial
The safety, immunogenicity and optimal dosing regimen of the MVA-MERS-S vaccine candidate have been investigated in a phase Ib study in healthy individuals who were previously infected with SARS-CoV-2.
-
NewsStudy reveals insights into oral HPV incidence and risks in men across 3 countries
A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil - the virus is linked to up to 90% of all oropharyngeal cancer cases in men in the U.S.
-
NewsmRNA vaccine created to prevent and treat C. difficile
The vaccine is the first mRNA vaccine against C. difficile and would be the first vaccine in general to successfully ward off the bacterial infection.
-
NewsWHO in Lebanon working to stop cholera spread amid conflict
On 16 October, the Ministry of Public Health of Lebanon confirmed a cholera case. Authorities are investigating the extent of the disease’s spread, gathering samples from the patient’s contacts, and assessing potential water contamination.
-
NewsNew international research alliance to tackle Mpox epidemic in Africa
MpoxVax AFRIVAC is a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.
-
NewsBig data study finds RSV vaccine highly effective in protecting older adults
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
-
NewsMpox vaccine is safe and generates a robust antibody response in adolescents
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.
-
NewsmRNA vaccines for disease outbreaks can be synthesized in less time with new technique
Researchers have developed an innovative synthesis technology capable of producing high purity, fully chemically synthesized mRNA, cutting out the slower enzyme reactions, which could lead to mitigation of future infections at a preliminary stage.
-
NewsHPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
